Ebola Drugs Should Be Limited to Trials, WHO Advisers Say (1)

Drugs in development to treat and prevent infections caused by the Ebola virus that’s circulating in the Democratic Republic of Congo and Uganda should be given only as part of clinical trials, advisers to the World Health Organization said.

That means people who are sick now, or are at risk of becoming sick after being exposed to them, may not get access. It has been extraordinarily difficult to develop Ebola drugs, given that the outbreaks emerge sporadically, often in remote areas, and kill patients so quickly.

WHO convened several expert advisory groups to assess potential medicines for the Bundibugyo strain ...